- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04391738
Association Between BMI and COVID-19 (BMI-SARS-CoV-2)
Relationship Between Obesity and Severe Acute Respiratory Syndrome Coronavirus-2 in Patient With SARS-CoV-2 Admitted in Intensive Care : A Multicenter Retrospective Cohort Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The COVID-19 pandemic is characterized by a high frequency of patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), who often require invasive mechanical ventilation (IMV). Body mass index (BMI) was however rarely mentioned in early clinical reports.
Disease severity gradually increased with body mass index (BMI) categories among patients admitted in intensive care unit (ICU) for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the need for invasive mechanical ventilation (IMV), reaching 85% in patients with class II or III obesity ( BMI > 35 kg/m2).
In summary, there is an urgent need for more evidence on the specific role played by obesity in the development of COVID-19 complications, and more particularly of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Lille, France, 59100
- Centre Hospitalier Régional & Universitaire de Lille (CHRU)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Participant is aged 18 years or over
- Has been admitted to ICU with COVID-19 disease.
- COVID-19 disease has been confirmed by PCR for SARS-CoV-2
- Height and weight or BMI on admission has been recorded
- Data has been collected in an ethical manner as part of a national database or clinical auditing process approved by the local institution or collaboration
Exclusion Criteria:
-There are no exclusion criteria
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
BMI SARS-CoV-2
Patients admitted to Intensive Care Unit with SARS-CoV-2
|
Patients admitted to Intensive Care Unit with SARS-CoV2
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relationship between body mass index (BMI) and SARS-CoV-2
Time Frame: 3 months
|
The primary objective of this study is to investigate the relationship between obesity, as determined by body mass index (BMI), and severe pneumonia, as defined by the need of invasive mechanical ventilation ( IMV), among patient admitted in ICU for SARS-CoV-2, across multiple centers, in multiple countries.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Associations between BMI and outcomes is independent of the known cardiometabolic risk factors
Time Frame: 3 months
|
Investigate whether the associations between BMI and outcomes is independent of the known cardiometabolic risk factors, hypertension, diabetes, dyslipidemia, and current smoking.
|
3 months
|
|
Investigate the modifying effects of age and sex on the associations between BMI and outcome: Invasive mechanical ventilation
Time Frame: 3 months
|
Investigate the modifying effects of age and sex on the associations between BMI and outcome: Invasive mechanical ventilation
|
3 months
|
|
Investigate the modifying effects of age and sex on the associations between BMI and outcome: mortality
Time Frame: 3 months
|
Investigate the modifying effects of age and sex on the associations between BMI and outcome: mortality
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Francois Pattou, MD, Centre Hospitalier Régional & Universitaire de Lille (CHRU)
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- DEC20-095
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on SARS-CoV 2
-
AIM Vaccine Co., Ltd.Zhejiang Provincial Center for Disease Control and PreventionNot yet recruiting
-
AIM Vaccine Co., Ltd.First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological...Not yet recruiting
-
AIM Vaccine Co., Ltd.First Affiliated Hospital Bengbu Medical CollegeActive, not recruiting
-
AIM Vaccine Co., Ltd.Hunan Provincial Center for Disease Control and PreventionCompleted
-
Indiana UniversityCompletedSARS-CoV-2United States
-
Peking UniversityCenters for Disease Control and Prevention, China; Beijing Pinggu District... and other collaboratorsCompleted
-
University Hospital, Montpelliersociete SkillCell - 97198 Jarry; CNRS Alcediag UMR9005 - societe Sys2Diag -...Completed
-
Centre Hospitalier Universitaire DijonCompleted
-
Generate BiomedicinesCompleted
-
Arcturus Therapeutics, Inc.Terminated
Clinical Trials on Patients admitted to Intensive Care Unit with SARS-CoV2
-
Pontificia Universidad Catolica de ChileCompleted
-
Nantes University HospitalRecruitingIntraventricular Hemorrhage | Intensive Care Unit | External Ventricular DrainFrance
-
Nantes University HospitalRecruitingNosocomial Infection | Coronavirus Infectious Disease (COVID-19) | Nosocomial COVID-19France
-
Hospices Civils de LyonRecruiting
-
Nantes University HospitalCompletedIntensive Care Units | Arterial LinesFrance
-
The University of QueenslandTan Tock Seng Hospital; University of North Carolina, Chapel Hill; Royal Brisbane... and other collaboratorsCompletedCOVID-19Thailand, United States, Australia, Singapore, India
-
Nantes University HospitalCompleted
-
Nantes University HospitalAssistance Publique - Hôpitaux de Paris; Assistance Publique Hopitaux De MarseilleCompletedStress Disorders, Post-Traumatic | Family MembersFrance, Guadeloupe
-
Nantes University HospitalCompletedIntensive Care Unit | Arterial CatheterFrance
-
Hospital de SaguntoBiopolis S.L.; Laboratorios Heel EspañaUnknown